{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:38:00Z","timestamp":1789879080057,"version":"4.0.1"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T00:00:00Z","timestamp":1443744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0004087","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T17:59:28Z","timestamp":1443808768000},"page":"e0004087","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":56,"title":["Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study"],"prefix":"10.1371","volume":"9","author":[{"given":"Ermias","family":"Diro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koert","family":"Ritmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Boelaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezika","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Abongomera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Ravinetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"De Crop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helina","family":"Fikre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherinet","family":"Adera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Colebunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"van Loen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"Menten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutgarde","family":"Lynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asrat","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"van Griensven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,10,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"20546","DOI":"10.2807\/1560-7917.ES2013.18.30.20546","article-title":"Re-emergence of leishmaniasis in Spain: community outbreak in Madrid, Spain, 2009 to 2012","volume":"18","author":"A Arce","year":"2013","journal-title":"Euro Surveill"},{"issue":"Suppl 1","key":"ref2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1179\/000349803225002615","article-title":"The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV","volume":"97","author":"R Lopez-Velez","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/00365540151061049","article-title":"Visceral leishmaniasis in an AIDS patient on successful antiretroviral therapy: failure of parasite eradication despite increase in CD4+ T-cell count but low CD8+ T-cell count","volume":"33","author":"A Petter","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"ref4","unstructured":"World Health Organization (2007) Report of the Fifth Consultative Meeting on <italic>Leishmania<\/italic>\/HIV Coinfection, March 20\u201322, Addis Ababa, Ethiopia."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e3021","DOI":"10.1371\/journal.pntd.0003021","article-title":"Visceral leishmaniasis and HIV coinfection in the Mediterranean region","volume":"8","author":"B Monge-Maillo","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl 1","key":"ref6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1179\/000349803225002516","article-title":"HIV and the transmission of Leishmania","volume":"97","author":"R Molina","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/JCM.41.11.5080-5084.2003","article-title":"Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis","volume":"41","author":"S Bossolasco","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/BF01700556","article-title":"Visceral leishmaniasis in patients infected with the human immunodeficiency virus","volume":"16","author":"F Laguna","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/jac\/dkh084","article-title":"Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients","volume":"53","author":"R Lopez-Velez","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00005792-200101000-00006","article-title":"Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study","volume":"80","author":"V Pintado","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0002-9343(97)89503-4","article-title":"Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients","volume":"100","author":"E Ribera","year":"1996","journal-title":"Am J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1468-1293.2010.00846.x","article-title":"&apos;Active chronic visceral leishmaniasis&apos; in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients","volume":"11","author":"N Bourgeois","year":"2010","journal-title":"HIV Med"},{"key":"ref13","unstructured":"[Anonymous] (2014) Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. T-15-T-25."},{"key":"ref14","unstructured":"World Health Organization (3-22-2010) Control of the Leishmaniases. WHO Technical Report Series 949: Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22\u201326 March 2010. Geneva, Swetzerland: World Health Organization."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jac\/dkm294","article-title":"Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients","volume":"60","author":"I Molina","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00002030-199602000-00023","article-title":"Pentamidine isethionate as secondary prophylaxis against visceral leishmaniasis in HIV-positive patients","volume":"10","author":"JA Perez-Molina","year":"1996","journal-title":"AIDS"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1086\/587899","article-title":"Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome","volume":"46","author":"R ter Horst","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1179\/joc.2001.13.6.653","article-title":"Pentamidine isethionate as treatment and secondary prophylaxis for disseminated cutaneous leishmaniasis during HIV infection: case report","volume":"13","author":"L Calza","year":"2001","journal-title":"J Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1365-3156.2009.02329.x","article-title":"Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases","volume":"14","author":"TA Patel","year":"2009","journal-title":"Trop Med Int Health"},{"key":"ref20","year":"2008","unstructured":"[Anonymous] (<year>2008<\/year>) <chapter-title>Guidelines for management of opportunistic infections and antiretroviral treatment in adolescents and adults in Ethiopia<\/chapter-title>, <publisher-name>Federal HIV\/AIDS Prevention and Control Office, Federal Ministry of Health<\/publisher-name>."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e1153","DOI":"10.1371\/journal.pntd.0001153","article-title":"Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review","volume":"5","author":"GF Cota","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1371\/journal.pntd.0000225","article-title":"Pentamidine dosage: a base\/salt confusion","volume":"2","author":"TP Dorlo","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/BF01744270","article-title":"Visceral leishmaniasis in an HIV-infected patient: clinical features and response to treatment","volume":"69","author":"S Fenske","year":"1991","journal-title":"Klin Wochenschr"},{"key":"ref24","unstructured":"Gazapo E (2010) Visceral leishmaniasis secondary prophylaxis in HIV patients. Int Conf AIDS."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00002030-199202000-00020","article-title":"Visceral leishmaniasis and HIV infection: unusual presentation with pleuropulmonary involvement, and effect of secondary prophylaxis","volume":"6","author":"S Matheron","year":"1992","journal-title":"AIDS"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e3011","DOI":"10.1371\/journal.pntd.0003011","article-title":"A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?","volume":"8","author":"GJ van","year":"2014","journal-title":"PLoS Negl Trop Dis"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0004087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T05:42:48Z","timestamp":1540273368000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0004087"}},"subtitle":[],"editor":[{"given":"Hechmi","family":"Louzir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,2]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0004087","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,2]]}}}